Skip to main content

Table 2 Case series

From: Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach

 

Training set

n = 40

Validation set

n = 40

P valuea

Age, years

 ≤70

32

33

0.775

 >70

8

7

 

Gleason score

 ≤6

18

13

0.251

 >6

22

27

 

Pathological stage

 T2a

5

5

 

 T2b

1

0

 

 T2c

17

16

0.554

 T3a

12

17

 

 T3b

5

2

 

Median PSA (range)

6.77 (3.19–33.14)

5.81 (2.65–24.00)

0.1988

  1. aThe two groups were equally distributed for age, Gleason score, pathological stage and PSA. The Chi square test was used for age and Gleason score to determine statistical differences between training and validation sets; the Fisher test was used for pathological stage and the Wilcoxon test for PSA value